| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
3,512,000
|
3,194,000
|
3,218,000
|
3,320,000
| | Cost of Revenue | 3,226,000 | 2,933,000 | 2,997,000 | 3,120,000 | | |
Gross Profit
|
286,000
|
261,000
|
221,000
|
200,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 57,000 | 34,000 | 30,000 | (1,000) |
|
Non Recurring |
-
|
-
|
-
| (10,000) |
|
Others | 64,000 | 63,000 | 26,000 | 25,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
165,000
|
164,000
|
165,000
|
186,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 2,000 |
-
|
-
| (2,000) |
|
Earnings Before Interest And Taxes | 167,000 | 164,000 | 165,000 | 184,000 |
|
Interest Expense | 19,000 | 14,000 | 20,000 | 21,000 |
|
Income Before Tax | 148,000 | 150,000 | 145,000 | 163,000 |
|
Income Tax Expense | 6,000 | 8,000 | 8,000 | 8,000 |
|
Minority Interest | (2,000) | (3,000) | (3,000) | (3,000) |
|
|
|
Net Income From Continuing Ops | 140,000 | 139,000 | 134,000 | 152,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
140,000
|
139,000
|
134,000
|
152,000
| | Preferred Stock And Other Adjustments |
-
|
-
| 34,000 | (34,000) | | |
Net Income Applicable To Common Shares
|
140,000
|
139,000
|
168,000
|
118,000
|
|
0.10(0.16%) 1:40PM EDT - Nasdaq Real Time Price